- Children with cochlear implants aged 2 years and older who have completed the pneumococcal conjugate vaccine (Prevnar®) series should receive one dose of the pneumococcal polysaccharide vaccine (Pneumovax® 23). If they have just received pneumococcal conjugate vaccine, they should wait at least two months before receiving pneumococcal polysaccharide vaccine.
- Children with cochlear implants between 24 and 59 months of age who have never received either pneumococcal conjugate vaccine or pneumococcal polysaccharide vaccine should receive two doses of pneumococcal conjugate vaccine two or more months apart and then receive one dose of pneumococcal polysaccharide vaccine at least two months later.
- Persons aged 5 years and older with cochlear implants should receive one dose of pneumococcal polysaccharide vaccine.
Cochlear Implants and Immunization, CDC Fact Sheet
Recommendations from the Centers for Disease Control and Prevention and the US Food and Drug Administration.
Exploring the Possibilities (NCHAM - Wisconsin) ( 449 KB)
From the site of the National Center for Hearing Assessment and Management and Wisconsin's Babies & Hearing: An Interactive Notebook for Families With a Young Child Who Is Deaf or Hard of Hearing, providing a detailed overview of choices for supporting children with hearing impairment.
Cochlear Implants (NIDCD)
From the National Institute on Deafness and Other Communication Disorders, this page offers an overview of cochlear implants and links to more information.
Cochlear Implants: Yesterday, Today, Tomorrow (NIH Research Timelines)
From the National Institutes of Medicine, a perspective on research about cochlear implants and a prediction for its future.
Cochlear Implants (ASHA)
From the American Speech-Language-Hearing Association, an overview of cochlear implants.
See all Audiology services providers (69) in our database.
See all Pediatric Otolaryngology services providers (9) in our database.
For other services related to this condition, browse our Services categories or search our database.
Cochlear Implants (clinicaltrials.gov)
Listing of clinical trials of which may be recruiting subjects; National Institutes of Health.
Zwolan TA, Zimmerman-Phillips S, Ashbaugh CJ, Hieber SJ, Kileny PR, Telian SA.
Cochlear implantation of children with minimal open-set speech recognition skills.
Ear Hear. 1997;18(3):240-51. PubMed abstract
Waltzman SB, Cohen NL.
Cochlear implantation in children younger than 2 years old.
Am J Otol. 1998;19(2):158-62. PubMed abstract
Rauschecker JP, Shannon RV.
Sending sound to the brain.
Science. 2002;295(5557):1025-9. PubMed abstract
Bishop CE, Eby TL.
The current status of audiologic rehabilitation for profound unilateral sensorineural hearing loss.
Laryngoscope. 2010;120(3):552-6. PubMed abstract
Belzner KA, Seal BC.
Children with cochlear implants: a review of demographics and communication outcomes.
Am Ann Deaf. 2009;154(3):311-33. PubMed abstract
|Content Last Updated:||8/2010|
Centers for Disease Control and Prevention.
Use of Meningitis Vaccine in Persons with Cochlear Implants.
Department of Health and Human Services; (2007) http://www.cdc.gov/vaccines/vpd-vac/mening/cochlear/dis-cochlear-gen.h.... Accessed on 3/22/2010.
Reefhuis J, Honein MA, Whitney CG, Chamany S, Mann EA, Biernath KR, Broder K, Manning S, Avashia S, Victor M, Costa P, Devine
O, Graham A, Boyle C.
Risk of bacterial meningitis in children with cochlear implants.
N Engl J Med. 2003;349(5):435-45. PubMed abstract